Govt Partnerships Aktiv Pharma has a history of BARDA funding and involvement in FDA pathways for autoinjector programs, signaling strong regulatory credibility and government procurement experience. This creates opportunities to offer contract manufacturing, regulatory consulting, sterile filling and packaging, and supply-chain services to government or defense-related autoinjector initiatives.

Home Self-Care The PenPal autoinjector platform targets self-administration of complex injections, aligning with markets for chronic conditions, outpatient care, and home health. Sales opportunities exist through partnerships with hospitals, clinics, pharmacies, and home infusion providers, complemented by patient training and reimbursement-ready programs.

Colorado Footprint Based in Louisville with prior expansion to Broomfield, Aktiv Medical Systems is well positioned in the Colorado biotech cluster with access to regional talent and suppliers. Opportunities include regional partnerships with biopharma startups, contract manufacturers, and academic collaborators to accelerate development and scale.

Training & Adoption Autoinjector adoption hinges on effective patient and caregiver education. There is potential to offer end-to-end training, adherence support, remote monitoring, and data-sharing solutions to clinics and payers, enhancing device utilization and outcomes.

Scale & Supply With a lean team and modest revenue, there is a clear path for contract manufacturing and supply-chain services that can scale with demand. Positioning as a turnkey autoinjector supplier—covering design transfer, GMP manufacturing, sterile filling, assembly, packaging, and serialization—could attract larger medtech partners seeking regulatory-ready capabilities.